James Healy, Director at Rapport Therapeutics, Inc. (RAPP), bought 88,064 shares at $25.02 ($2.2M) on 2024-07-01, disclosed to the SEC on 2024-07-03.
Open-market purchase of $2.2M RAPP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.08 | 3,799 | $88K | 4.1% |
| 2 | $23.08 | 3,799 | $88K | 4.1% |
| 3 | $23.08 | 3,538 | $82K | 3.8% |
| 4 | $23.08 | 3,538 | $82K | 3.8% |
| 5 | $23.08 | 3,630 | $84K | 3.9% |
| 6 | $23.08 | 3,630 |
| $84K |
| 3.9% |
| 7 | $24.21 | 3,565 | $86K | 4.0% |
| 8 | $24.21 | 3,828 | $93K | 4.3% |
| 9 | $24.21 | 3,828 | $93K | 4.3% |
| 10 | $24.21 | 3,657 | $89K | 4.1% |
| 11 | $24.21 | 3,657 | $89K | 4.1% |
| 12 | $24.21 | 3,565 | $86K | 4.0% |
| 13 | $25.02 | 4,878 | $122K | 5.7% |
| 14 | $25.02 | 4,544 | $114K | 5.3% |
| 15 | $25.02 | 4,544 | $114K | 5.3% |
| 16 | $25.02 | 4,661 | $117K | 5.4% |
| 17 | $25.02 | 4,661 | $117K | 5.4% |
| 18 | $25.02 | 4,878 | $122K | 5.7% |
| 19 | $26.06 | 2,559 | $67K | 3.1% |
| 20 | $26.06 | 2,748 | $72K | 3.3% |
| 21 | $26.06 | 2,748 | $72K | 3.3% |
| 22 | $26.06 | 2,625 | $68K | 3.2% |
| 23 | $26.06 | 2,625 | $68K | 3.2% |
| 24 | $26.06 | 2,559 | $67K | 3.1% |
| Total | $24.52 avg | 88,064 | $2.2M | 100% |
| Filing → |
| AVBP | BUY | 2024-01-31 | $8.0M | — | Filing → |
| NTRA | SELL | 2023-12-22 | $37.8M | — | Filing → |
| CINC | SELL | 2023-02-27 | $86K | — | Filing → |